The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Bitterman Robert J

Reporting owner CIK 0001304395 · Chairman, Pres. & CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Bitterman Robert JBitterman Robert JBitterman Robert J · December 31, 2025 · Purchase · Common Stock, $.0001 par valueBitterman Robert J · December 23, 2025 · Purchase · Common Stock, $.0001 par valueBitterman Robert J · November 21, 2025 · Purchase · Common Stock, $.0001 par valueBitterman Robert J · November 18, 2025 · Purchase · Common Stock, $.0001 par valueNov 18, 2025Dec 31, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 31, 2025Phio Pharmaceuticals Corp.Common Stock, $.0001 par valueBitterman Robert JPurchase
Dec 23, 2025Phio Pharmaceuticals Corp.Common Stock, $.0001 par valueBitterman Robert JPurchase
Nov 21, 2025Phio Pharmaceuticals Corp.Common Stock, $.0001 par valueBitterman Robert JPurchase
Nov 18, 2025Phio Pharmaceuticals Corp.Common Stock, $.0001 par valueBitterman Robert JPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Phio Pharmaceuticals Corp.PHIO · company listings
Bitterman Robert JChairman, Pres. & CEO · Director
PurchaseCommon Stock, $.0001 par valueNon-derivative security · Code P5,0001.03Value: 5,150Currency not specifiedView ↗
Trade: Phio Pharmaceuticals Corp.PHIO · company listings
Bitterman Robert JChairman, Pres. & CEO · Director
PurchaseCommon Stock, $.0001 par valueNon-derivative security · Code P5,0001.02Value: 5,100Currency not specifiedView ↗
Trade: Phio Pharmaceuticals Corp.PHIO · company listings
Bitterman Robert JChairman, Pres. & CEO · Director
PurchaseCommon Stock, $.0001 par valueNon-derivative security · Code P5,0001.14Value: 5,700Currency not specifiedView ↗
Trade: Phio Pharmaceuticals Corp.PHIO · company listings
Bitterman Robert JChairman, Pres. & CEO · Director
PurchaseCommon Stock, $.0001 par valueNon-derivative security · Code P5,0001.27Value: 6,350Currency not specifiedView ↗